Johnson & Johnson to Buy $1 Billion Elan Corporation PLC Stake, Work on Alzheimer’s
Wednesday, July 1st, 2009
Bloomberg -- Johnson & Johnson agreed to pay $1 billion for a stake in Elan Corp. and will develop the Irish drugmakers medicines against Alzheimers disease.
